(Q51553641)

7 April 2018

title

The increased insulin sensitivity in growth hormone-deficient adults is reduced by growth hormone replacement therapy. (English)

1 reference

7 April 2018

1 reference

Alexandra Kautzky-Willer

7

object named as

Kautzky-Willer A

1 reference

7 April 2018

author name string

Riedl M

1

1 reference

7 April 2018

Ludvik B

2

1 reference

7 April 2018

Pacini G

3

1 reference

7 April 2018

Clodi M

4

1 reference

7 April 2018

Kotzmann H

5

1 reference

7 April 2018

Wagner O

6

1 reference

7 April 2018

Prager R

8

1 reference

7 April 2018

Luger A

9

1 reference

7 April 2018

publication date

1 September 2000

1 reference

7 April 2018

European Journal of Clinical Investigation

published in

1 reference

7 April 2018

volume

30

1 reference

7 April 2018

issue

9

1 reference

7 April 2018

page(s)

771-778

1 reference

7 April 2018

Premature mortality due to cardiovascular disease in hypopituitarism

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2000.00695.X

Increased cerebrovascular mortality in patients with hypopituitarism

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2000.00695.X

Detection of premature atherosclerosis by high-resolution ultrasonography in symptom-free hypopituitary adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2000.00695.X

Left ventricular function in young adults with childhood and adulthood onset growth hormone deficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2000.00695.X

Increased body fat mass and decreased extracellular fluid volume in adults with growth hormone deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2000.00695.X

Studies of hyperlipidemia in the HGH-deficient state.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2000.00695.X

Metabolic effects of hypopituitarism and acromegaly

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2000.00695.X

Insulin resistance, hyperinsulinemia, hypertriglyceridemia, and hypertension. Parallels between human disease and rodent models

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2000.00695.X

Clinical aspects of growth hormone deficiency in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2000.00695.X

Effect of long-term growth-hormone substitution therapy on bone mineral density and parameters of bone metabolism in adult patients with growth hormone deficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2000.00695.X

The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2000.00695.X

The Australian Multicenter Trial of Growth Hormone (GH) Treatment in GH-Deficient Adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2000.00695.X

Decreased peripheral insulin sensitivity in acromegalic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2000.00695.X

Growth hormone treatment of adults with growth hormone deficiency: results of a 13-month placebo controlled cross-over study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2000.00695.X

Effects of treatment with recombinant human growth hormone on insulin sensitivity and glucose metabolism in adults with growth hormone deficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2000.00695.X

Lilly lecture 1989. Toward physiological understanding of glucose tolerance. Minimal-model approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2000.00695.X

Insulin secretion and hepatic extraction in humans by minimal modeling of C-peptide and insulin kinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2000.00695.X

MINMOD: a computer program to calculate insulin sensitivity and pancreatic responsivity from the frequently sampled intravenous glucose tolerance test.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2000.00695.X

Mathematical models of insulin secretion in physiological and clinical investigations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2000.00695.X

Estimation of beta-cell secretion and insulin hepatic extraction by the minimal modelling technique.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2000.00695.X

Cholinergic agonist and antagonist drugs modulate the growth hormone response to growth hormone-releasing hormone in the rat: evidence for mediation by somatostatin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2000.00695.X

Equivalence of the insulin sensitivity index in man derived by the minimal model method and the euglycemic glucose clamp

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2000.00695.X

Elevated islet amyloid pancreatic polypeptide and proinsulin in lean gestational diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2000.00695.X

Elevated hepatic insulin extraction in essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2000.00695.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2000.00695.X

The effects of growth hormone on carbohydrate and lipid metabolism in the dog

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2000.00695.X

Treatment with a somatostatin analog decreases pancreatic B-cell and whole body sensitivity to glucose.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2000.00695.X

Recombinant deoxyribonucleic acid-derived 22K- and 20K-human growth hormone generate equivalent diabetogenic effects during chronic infusion in dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2000.00695.X

Role of glucose effectiveness in the determination of glucose tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2000.00695.X

10.1046/J.1365-2362.2000.00695.X

21 January 2018

Identifiers

DOI

1 reference

7 April 2018

PubMed ID

10998076

1 reference

7 April 2018